Using genomics in medicine
“Last year Sozzani’s son, the photographer and filmmaker Francesco Carrozzini, established the Franca Sozzani Fund for Preventive Genomics at Harvard University’s Brigham and Women’s Hospital with artist and investor D.A. Wallach and Genomes2People director Dr. Robert C. Green. Today marks the launch of thefrancafund.org. Its purpose is straightforward: to explain the fund’s mission, provide resources … Continued
Race is a social construct, but representation matters in genetic studies — and on that front, we have a long way to go. By Tala Berro, MS, CGC
In this study led by UCSF researchers, exome sequencing was found to produce more false positives and false negatives for inherited metabolic disorders than the standard blood testing conducted in newborns. G2P’s Dr. Robert Green, co-leader of the BabySeq Project, speaks to the possibility “that the most comprehensive screening for newborns will be some combination … Continued
Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.
Our genes might make some of us more susceptible to COVID-19—but which genes? Geneticists are sharing their vast DNA databases to find out.
“..There are researchers – every single scientist is thinking ‘how can I contribute?’”
“While healthy young people as a group are less likely to have severe symptoms with COVID, they have to understand that some of them will become very ill and will even die from this infection,” Dr. Robert Green said. “No one should assume youth makes them invulnerable.”
An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH
Greg and Robert explode some of the persistent myths around genetic testing and dive in to the future of genetic testing amongst healthy populations
Through national research efforts like the All of Us Research Program, Brigham investigators and their collaborators are making genomic research more meaningful, equitable and impactful for all patients at the Brigham and around the world.
Whole genome tests can help identify the cause of a baby’s mysterious illness. But ethicists say it’s still too soon to use them for all infants.
“Our research is finding that genetics is about to take its rightful place in medical care for the world.” said Dr. Robert Green, a professor of genetics at Harvard Medical School.
“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”
Companies claim they can now easily calculate your biological age. Should you take them up on it?
A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”
“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.
Genetic counselors are becoming a bigger part of the healthcare continuum as population health management seeks to more quickly screen for, assess and prevent illness. Read on as genetic counselors in the field, including our own, Carrie Blout, address some of the barriers in genetic counseling.
BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.